When analyzing disease-free survival, the high expression of SAMD13 is associated with a worse prognosis in LGG, LICH, and LUAD, while the low expression of SAMD13 indicated better prognosis in COAD, GBM, KIRC, and THCA. Here, SAMD13 is linked to colon adenocarcinoma.